Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $131.67 | 9 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $58.39 | 4 | $0 (2024) |
| Dynavax Technologies Corporation | $29.23 | 2 | $0 (2023) |
| AbbVie Inc. | $15.26 | 1 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $14.97 | 1 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $13.82 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $28.68 | 2 | Novo Nordisk Inc ($14.86) |
| 2023 | $75.71 | 5 | Novo Nordisk Inc ($43.53) |
| 2022 | $12.31 | 1 | Dynavax Technologies Corporation ($12.31) |
| 2018 | $14.97 | 1 | Merck Sharp & Dohme Corporation ($14.97) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/28/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Respiratory | ||||||
| 02/27/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Obesity | ||||||
| 12/05/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Diabetes | ||||||
| 09/20/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Diabetes | ||||||
| 05/25/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: Obesity | ||||||
| 03/31/2023 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Hepatitis B Vaccine | ||||||
| 11/14/2022 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $12.31 | General |
| Category: Hepatitis B Vaccine | ||||||
| 09/11/2018 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: WOMENS HEALTH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 1,396 | 1,747 | $231,836 | $62,223 |
| 2022 | 14 | 539 | 714 | $150,596 | $39,402 |
| 2021 | 6 | 144 | 160 | $36,429 | $10,795 |
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 134 | 227 | $75,818 | $18,886 | 24.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 112 | 112 | $44,016 | $13,438 | 30.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 75 | 98 | $21,952 | $4,392 | 20.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $19,342 | $3,990 | 20.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 11 | 11 | $6,992 | $3,112 | 44.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 37 | 37 | $6,771 | $2,579 | 38.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 156 | 254 | $5,080 | $2,134 | 42.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 134 | 160 | $6,400 | $2,086 | 32.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 30 | 30 | $8,100 | $1,947 | 24.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 141 | 174 | $6,960 | $1,791 | 25.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 67 | 76 | $3,800 | $1,251 | 32.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 39 | 39 | $3,198 | $1,227 | 38.4% |
| 96136 | Administration of psychological or neuropsychological test, first 30 minutes | Office | 2023 | 31 | 31 | $4,960 | $982.08 | 19.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 83 | 100 | $2,500 | $761.00 | 30.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 53 | 71 | $2,059 | $666.40 | 32.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $3,663 | $497.52 | 13.6% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 30 | 31 | $1,519 | $458.18 | 30.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 12 | 12 | $984.00 | $377.64 | 38.4% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 17 | 19 | $760.00 | $253.84 | 33.4% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 33 | 43 | $1,720 | $243.38 | 14.2% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 23 | 27 | $810.00 | $238.68 | 29.5% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 33 | 43 | $860.00 | $218.44 | 25.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 17 | 18 | $1,278 | $182.75 | 14.3% |
| 83550 | Iron binding capacity | Office | 2023 | 17 | 19 | $494.00 | $162.83 | 33.0% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 16 | 16 | $640.00 | $132.64 | 20.7% |
About Dr. Aileen Souza, MD
Dr. Aileen Souza, MD is a Family Medicine healthcare provider based in Dartmouth, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/04/2018. The National Provider Identifier (NPI) number assigned to this provider is 1598261745.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aileen Souza, MD has received a total of $131.67 in payments from pharmaceutical and medical device companies, with $28.68 received in 2024. These payments were reported across 9 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($131.67).
As a Medicare-enrolled provider, Souza has provided services to 2,079 Medicare beneficiaries, totaling 2,621 services with total Medicare billing of $112,419. Data is available for 3 years (2021–2023), covering 48 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Dartmouth, MA
- Active Since 04/04/2018
- Last Updated 04/25/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1598261745
Products in Payments
- Heplisav-B (Drug) $29.23
- Wegovy (Drug) $27.61
- Ozempic (Drug) $16.57
- UBRELVY (Drug) $15.26
- NEXPLANON (Drug) $14.97
- Rybelsus (Drug) $14.21
- BREZTRI (Drug) $13.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Dartmouth
Stephen Butler, Do, DO
Family Medicine — Payments: $4,089
Dr. Justin Etter, Do, DO
Family Medicine — Payments: $666.82
Dr. Elaine Wu, M.d, M.D
Family Medicine — Payments: $517.15
Dr. Robert Caldas, Do, DO
Family Medicine — Payments: $251.21
Dr. Ashley Vertente, Md, MD
Family Medicine — Payments: $123.51
Kimberly Lewis, Md, MD
Family Medicine — Payments: $109.77